Genetic Heterogeneity in Colorectal Cancer and its Clinical Implications

**** upper normal limit value... Circulating Methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Liquid biopsies: genotyping circulating tumor DNA.

The results of a multicentre, international (West- ern Europe, Central Europe, Eastern Europe, Cana- da, Australia, New Zealand), open-label phase III Ran- domized Controlled

Na Tabela 7, verificam-se as médias da umidade relativa do ar mínima mensal e anual registradas no período de 2009 a 2016 na estação meteorológica automática do assentamento rural

In summary, our study showed that PNA-PCR method could easily detect the percentage of KRAS mutation in tumor cells and colorectal cancer patients with low abundance of KRAS

A modernidade é um período histórico de difícil delimitação. 9), foi Hegel quem pela primeira vez tomou consciência da relação interna entre modernidade e

A Matemática surge no nosso dia-a-dia em inúmeras situações, sendo necessário recorrer a ela, para resolver diversos problemas. Há que incutir o gosto por esta

Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with.. Moerkerk P, Arends JW,

The aim of this study was to evaluate the rate of surgical treatment of recurrence with curative intent in our program; secondary outcomes were: colorectal cancer